Decreased carbonyl reductase 1 expression promotes malignant behaviours by induction of epithelial mesenchymal transition and its clinical significance

Cancer Letters

Volumn 323, Issue 1, 2012, Pages 69-76

  Murakami, Akihiro ^a   Yakabe, Kazuyuki ^a   Yoshidomi, Keiko ^a   Sueoka, Kotaro ^a   Nawata, Shugo ^a   Yokoyama, Yoshihito ^b   Tsuchida, Shigeki ^b   Al Mulla, Fahd ^c   Sugino, Norihiro ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HIROSAKI UNIVERSITY   (Japan)

^c KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Carbonyl reductase 1 (CBR1); E cadherin; Endometrial cancer; Epithelial mesenchymal transition (EMT); Mesenchymal epithelial transition (MET)

Indexed keywords

CARBONYL REDUCTASE; CARBONYL REDUCTASE 1; COMPLEMENTARY DNA; MATRIX METALLOPROTEINASE; MESSENGER RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SNAIL; UNCLASSIFIED DRUG; UVOMORULIN; ZEB1 PROTEIN;

ADULT; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELL AGGREGATION; CELL SHAPE; CONTROLLED STUDY; E CADHERIN GENE; ENDOMETRIUM CARCINOMA; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME MECHANISM; ENZYME RELEASE; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MAJOR CLINICAL STUDY; METASTASIS; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; REPRESSOR GENE; SNAIL GENE; TRANSCRIPTION TERMINATION; TUMOR PROMOTION; ZEB1 GENE;

ADENOCARCINOMA; ALCOHOL OXIDOREDUCTASES; BLOTTING, WESTERN; CELL LINE, TUMOR; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

GASTROPODA;

EID: 84861819415     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2012.03.035     Document Type: Article

References (23)

1. Penning T.M., Drury J.E. Human aldo-keto reductases: function, gene regulation, and single nucleotide polymorphisms. Arch. Biochem. Biophys. 2007, 464:241-250.
2. Mindnich R.D., Pennning T.M. Aldo-keto reductase (AKR) superfamily: genomics and annotation. Hum. Genomics. 2009, 3:362-370.
3. Miura T., Nishinaka T., Terada T. Different functions between human monomeric carbonyl reductase 3 and carbonyl reductase 1. Mol. Cell Biochem. 2008, 315:113-121.
4. Gonzales-Covarrubias V., Ghosh D., Lakhman S.S., Pendyala L., Blanco J.G. A functional genetic polymorphism on human carbonyl reductase 1 (CBRV881) inpacts on catalytic activity and NADPH binding affinity. Drug. Metab. Dispos. 2007, 35:973-980.
5. Ismail E., Al-Mulla F., Tsuchida S., Suto K., Motley P., Harrison P.R., Birnie G.D. Carbonyl reductase: a novel metastasis-modulating function. Cancer Res. 2000, 60:1173-1176.
6. Murakami A., Fukushima C., Yoshidomi K., Sueoka K., Nawata S., Yokoyama Y., Tsuchida S., Ismail E., Al-Mulla F., Sugino N. Suppression of carbonyl reductase expression enhances malignant behaviour in uterine cervical squamous cell carcinoma: carbonyl reductase predicts prognosis and lymph node metastasis. Cancer Lett. 2011, 311:77-84.
7. Umemoto M., Yokoyama Y., Sato S., Tsuchida S., Al-Mulla F., Saito Y. Carbonyl reductase as a significant predictor of survival and lymph node metastasis in epithelial ovarian cancer. Brit. J. Cancer 2001, 85:1032-1036.
8. Schipper J.H., Frixen U.H., Behrens J., Unger A., Jahnke K., Birchmeier w. Birchmeier E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res. 1991, 51:6328-6337.
9. Thiery J.P., Sleeman J.P. Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol. 2006, 7:131-142.
10. Shook D., Keller Mechanisms R. Mechanics and function of epithelial-mesenchymal transitions in early development. Mech. Dev. 2003, 120:1351-1383.
11. Hay E.D. The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it. Dev. Dyn. 2005, 233:706-720.
12. Takeichi M. Cadherins in cancer: implications for invasion and metastasis. Curr. Opin. Cell Biol. 1993, 5:806-811.
13. Birchmeier W., Behrens J. Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim. Biophys. Acta 1994, 1198:11-26.
14. Ikeguchi M., Makino M., Kaibara N. Clinical significance of E-cadherin-catenin complex expression in metastatic foci of colorectal carcinoma. J. Surg. Oncol. 2001, 77:201-207.
15. Henning G., Behrens J., Truss M., Frisch S., Reichmann E., Birchmeier W. Progression of carcinoma cells in associated with alternations in chromatin structure and factor binding at the E-cadherin promoter in vivo. Oncogene 1995, 11:475-484.
16. Cano A., Perez-Moreno M.A., Rodrigo I., Locascio A., Blanco M.J., del Barrio M.G., Portillo F., Nieto M.A. The transcriptional factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat. Cell Biol. 2000, 2:76-83.
17. Batlle E., Sancho E., Franci C., Dominguez D., Monfar M., Baulida J., Garcia De Herreros A. The transcriptional factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat. Cell Biol. 2000, 2:84-89.
18. Vernon A.E., LaBonne C. Tumor metastasis: a new twist on epithelial-mesenchymal transitions. Curr. Biol. 2004, 14:719-721.
19. Kim M.A., Lee H.S., Lee H.E., Kim J.H., Yang H.K., Kim W.H. Prognostic importance of epithelial-mesenchymal transition-related protein expression in gastric carcinoma. Histopathology 2009, 54:442-451.
20. Murakami A., Fukushima C., Yositomi K., Sueoka K., Nawata S., Fujimoto M., Nakamura K., Sugino N. Tumor-related protein, the squamous cell carcinoma antigen binds to the intracellular protein carbonyl reductase. Int. J. Oncol. 2010, 36:1395-1400.
21. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2002, 2:442-454.
22. Hugo H., Ackland M.L., Blick T., Lawrence M.G., Clements J.A., Williams E.D., Thompson E.W. Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J. Cell Physiol. 2007, 213:374-383.
23. Chao Y.L., Shepard C.R., Wells A. Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition. Mol. Cancer 2010, 9:179.